David Owens
Known title: Chief Medical OfficerCIK: 0001916664
David Owens's purchase track record
How the stock did after each of David Owens's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
9
of 9 since September 16, 2022
Stock higher 6 months later
44%
3 months: 33%
Median 6-month return
-17.3%
3 months: -29.1%
Beat the S&P 500
44%
median -12.2% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/4/2025 | NXL | $6K | -59.5% | -67.2% | +4.3% |
| 1/23/2025 | NXL | $7K | -28.8% | -54.2% | +4.0% |
| 1/13/2025 | NXL | $5K | -29.1% | -59.0% | +7.4% |
| 10/28/2024 | NXL | $1K | +18.2% | -17.3% | -5.1% |
| 8/13/2024 | NXL | $950 | +293.8% | +252.1% | +11.7% |
| 6/28/2024 | NXL | $2K | -58.2% | +74.6% | +9.3% |
| 6/18/2024 | NXL | $1K | -37.2% | +234.6% | +10.3% |
| 6/10/2024 | NXL | $2K | +22.7% | +559.1% | +12.9% |
| 9/16/2022 | NXL | $10K | -67.1% | -52.0% | +1.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| NXL | ▲ Buy | Grant | 36,459 | $0 | 9/29/2025 | View on chart |
| NXL | ▲ Buy | Open Market | 1,000 | $3K | 2/4/2025 | View on chart |
| NXL | ▲ Buy | Open Market | 1,000 | $3K | 2/4/2025 | View on chart |
| NXL | ▲ Buy | Open Market | 1,500 | $4K | 1/28/2025 | View on chart |
| NXL | ▲ Buy | Open Market | 1,000 | $3K | 1/23/2025 | View on chart |
| NXL | ▲ Buy | Open Market | 2,000 | $5K | 1/13/2025 | View on chart |
| NXL | ▲ Buy | Open Market | 500 | $1K | 10/28/2024 | View on chart |
| NXL | ▲ Buy | Open Market | 1,000 | $950 | 8/13/2024 | View on chart |
| NXL | ▲ Buy | Open Market | 1,000 | $2K | 6/28/2024 | View on chart |
| NXL | ▲ Buy | Open Market | 1,619 | $1K | 6/18/2024 | View on chart |
| NXL | ▲ Buy | Open Market | 1,000 | $620 | 6/10/2024 | View on chart |
| NXL | ▲ Buy | Open Market | 2,000 | $1K | 6/10/2024 | View on chart |
| NXL | ▲ Buy | Open Market | 2,500 | $10K | 9/16/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
NXL Listed Among Stocks With Notable Price Movement
Nexalin Technology shares appeared in several daily market lists tracking top gainers and notable movers. The stock is currently flagged with a high beta signal, indicating it tends to move more sharply than the broader market. While specific company news was not provided, its inclusion in these lists highlights recent volatility in trading activity.
NXL Listed Among Stocks With Notable Price Movement. Nexalin Technology shares appeared in several daily market lists tracking top gainers and notable movers. The stock is currently flagged with a high beta signal, indicating it tends to move more sharply than the broader market. While specific company news was not provided, its inclusion in these lists highlights recent volatility in trading activity.